Date | Shareholder name | Reason of Disclosure | Buy/Sell and Involved Shares |
Average Price per share | Current Holdings | % of Issued Shares |
24/10/2024 | 1201(L) | -3,165,000(L) | HKD5.900(L) | 20,909,600(L) | 5.99 | |
23/10/2024 | Yu Xiaoyong | 1201(L) | -4,061,800(L) | HKD5.750(L) | 27,242,505(L) | 7.81 |
21/10/2024 | 1201(L) | -1,675,400(L) | HKD5.690(L) | 24,074,600(L) | 6.90 | |
04/10/2024 | LAV Asset Management (Hong Kong) Limited | 1201(L) | -1,432,200(L) | HKD7.502(L) | 17,237,175(L) | 4.94 |
04/10/2024 | Shi Yi | 1201(L) | -1,432,200(L) | HKD7.502(L) | 17,237,175(L) | 4.94 |
02/10/2024 | LAV Asset Management (Hong Kong) Limited | 1201(L) | -2,000,000(L) | HKD6.000(L) | 20,721,575(L) | 5.94 |
02/10/2024 | Shi Yi | 1201(L) | -2,000,000(L) | HKD6.000(L) | 20,721,575(L) | 5.94 |
30/09/2024 | Yu Xiaoyong | 1706(L) | 31,304,305(L) | 8.97 | ||
25/09/2024 | LAV Asset Management (Hong Kong) Limited | 1201(L) | -2,468,000(L) | HKD5.066(L) | 23,834,575(L) | 6.83 |
25/09/2024 | Shi Yi | 1201(L) | -2,468,000(L) | HKD5.066(L) | 23,834,575(L) | 6.83 |
05/09/2024 | Tian Wenzhi | 1201(L) | -2,655,855(L) | 115,884,090(L) | 33.20 | |
05/09/2024 | Halo Biomedical LP | 1213(L) | -2,655,855(L) | 15,344,145(L) | 4.40 | |
05/09/2024 | Halo Biomedical Investment II Limited | 1213(L) | -2,655,855(L) | 15,344,145(L) | 4.40 | |
05/09/2024 | Halo Biomedical Investment I Limited | 1213(L) | -2,655,855(L) | 15,344,145(L) | 4.40 | |
04/09/2024 | Shi Yi | 1213(L) | 27,721,575(L) | 27,721,575(L) | 7.94 | |
04/09/2024 | Tian Wenzhi | 1711(L) | +50,269,972(L) | 118,539,945(L) | 33.96 | |
04/09/2024 | Yu Xiaoyong | 1113(L) | +25,750,000(L) | 31,304,305(L) | 8.97 | |
04/09/2024 | LAV Asset Management (Hong Kong) Limited | 1213(L) | 27,721,575(L) | 27,721,575(L) | 7.94 | |
04/09/2024 | Halo Biomedical Investment II Limited | 1213(L) | 18,000,000(L) | 5.16 | ||
04/09/2024 | Halo Biomedical LP | 1213(L) | 18,000,000(L) | 5.16 | ||
04/09/2024 | 1113(L) | +25,750,000(L) | 25,750,000(L) | 7.38 | ||
04/09/2024 | 1213(L) | -25,750,000(L) | 11,030,390(L) | 43.87 | ||
04/09/2024 | Yu Xiaoyong | 1213(L) | -25,750,000(L) | 11,030,390(L) | 43.87 | |
04/09/2024 | Halo Biomedical Investment I Limited | 1213(L) | 18,000,000(L) | 5.16 | ||
04/09/2024 | Tian Wenzhi | 1711(L) | -50,269,972(L) | 0(L) | 0.00 | |
04/09/2024 | Ho Yao | 1701(L) | +4,002,918(L) | 16,011,675(L) | 4.59 | |
04/09/2024 | 1711(L) | -7,758,630(L) | 0(L) | 0.00 | ||
04/09/2024 | 1711(L) | -7,419,847(L) | 0(L) | 0.00 | ||
04/09/2024 | LAV Corporate V GP, Ltd. | 1213(L) | 15,178,770(L) | 15,178,770(L) | 4.35 | |
04/09/2024 | LAV GP V, L.P. | 1213(L) | 15,178,770(L) | 15,178,770(L) | 4.35 | |
04/09/2024 | LAV Biosciences Fund V, L.P. | 1213(L) | 15,178,770(L) | 15,178,770(L) | 4.35 | |
04/09/2024 | 1701(L) | +10,862,055(L) | 10,862,055(L) | 7.46 | ||
04/09/2024 | 1701(L) | +10,862,055(L) | 10,862,055(L) | 7.46 | ||
04/09/2024 | LAV ImmuneOnco Hong Kong Limited | 1213(L) | 15,178,770(L) | 15,178,770(L) | 4.35 | |
04/09/2024 | LAV ImmOn Hong Kong Limited | 1213(L) | 12,542,805(L) | 12,542,805(L) | 3.59 | |
03/09/2024 | 1701(L) | -7,967,925(L) | 0(L) | 0.00 | ||
03/09/2024 | Chen Fei | 1701(L) | -7,967,925(L) | 0(L) | 0.00 | |
03/09/2024 | GBA Fund Investment Limited | 1213(L) | 13,854,690(L) | 13,854,690(L) | 3.97 | |
03/09/2024 | GBA Fund Investment Limited | 1213(L) | 13,854,690(L) | 13,854,690(L) | 3.97 | |
03/09/2024 | Greater Bay Area Homeland Development Fund (GP) Limited | 1213(L) | 13,854,690(L) | 13,854,690(L) | 3.97 | |
1 2 |
Remark: | (L) - Long Position, (S) - Short Position, (P) Lending; |
Real time quote last updated: 13/11/2024 15:53 | |
Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |